The World Health Organization (WHO) and partners announced 10 projects that will receive almost US$ 2 million in grants to improve capacities in pathogen genomic surveillance.
Susan Tousi leaves Illumina to become CEO of liquid biopsy firm Delfi
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Susan Tousi, CEO of Delfi Diagnostics Courtesy of